# US 2012/0253020 A1 · Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253020 A1
- Document ID: US20120253020A1
- Status: Published application
- Kind: A1
- Application number: 13/454,642
- Filed: 2012-04-24
- Published: 2012-10-04
- Earliest claimed: 2000-05-30
- Inventors: Donald L. Durden
- Web page: https://patentgrep.com/patent/US20120253020A1

## CPC

- G01N 33/5011: {for testing antineoplastic activity}
- A61K 38/1709: {from mammals}
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 35/00: Antineoplastic agents
- A61P 35/04: specific for metastasis
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- G01N 2500/04: Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Methods are provided for the identification, biochemical characterization and therapeutic use of agents which impact PTEN, p53, PI-kinase and AKT mediated cellular signaling.

## Claims

### Claim 1

A method for identifying agents which modulate PTEN activity, comprising:
a) providing a host cell wherein PTEN is expressed;
b) contacting said host cell with a test agent suspected of modulating PTEN activity;
c) assessing said modulation as a function of alterations in activated AKT levels in the presence of said agent.

### Claim 2 (depends on 1)

A method as claimed in claim 1, wherein said PTEN is mutated.

### Claim 3 (depends on 2)

A method as claimed in claim 2, wherein said mutation in PTEN is selected from the group consisting of G129E, G129R, R130M and C124S.

### Claim 4 (depends on 2)

A method as claimed in claim 2, wherein said PTEN is inactive and said test agent suppresses concomittant AKT activating activity.

### Claim 5 (depends on 4)

A test agent identified by the method of claim 4.

### Claim at position 6

6-88. (canceled)
